Cargando…
Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidence
Alpha-1-antitrypsin (AAT), a serine protease inhibitor (serpin), is increasingly recognized to inhibit SARS-CoV-2 infection and counter many of the pathogenic mechanisms of COVID-19. Herein, we reviewed the epidemiologic evidence, the molecular mechanisms, and the clinical evidence that support this...
Autores principales: | Bai, Xiyuan, Schountz, Tony, Buckle, Ashley M., Talbert, Janet L., Sandhaus, Robert A., Chan, Edward D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317171/ https://www.ncbi.nlm.nih.gov/pubmed/37294003 http://dx.doi.org/10.1042/BST20230078 |
Ejemplares similares
-
Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19
por: Bai, Xiyuan, et al.
Publicado: (2022) -
Alpha-1-Antitrypsin Enhances Primary Human Macrophage Immunity Against Non-tuberculous Mycobacteria
por: Bai, Xiyuan, et al.
Publicado: (2019) -
Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19
por: Bai, Xiyuan, et al.
Publicado: (2021) -
Author Correction: Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19
por: Bai, Xiyuan, et al.
Publicado: (2022) -
Improving the Lives of Patients with Alpha-1 Antitrypsin Deficiency
por: Sandhaus, Robert A, et al.
Publicado: (2020)